Insider Selling: Kevin J. Kenny Sells 2,914 Shares of Cardiovascular Systems Stock (CSII)
Cardiovascular Systems (NASDAQ:CSII) VP Kevin J. Kenny sold 2,914 shares of the company’s stock on the open market in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $29.09, for a total value of $84,768.26. Following the completion of the sale, the vice president now directly owns 84,976 shares in the company, valued at approximately $2,471,952. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
Cardiovascular Systems (NASDAQ:CSII) traded up 1.84% during mid-day trading on Monday, hitting $29.87. The stock had a trading volume of 166,076 shares. Cardiovascular Systems has a 1-year low of $18.83 and a 1-year high of $37.73. The stock’s 50-day moving average is $28.88 and its 200-day moving average is $30.32. The company’s market cap is $924.7 million.
Cardiovascular Systems (NASDAQ:CSII) last posted its quarterly earnings results on Wednesday, August 6th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by $0.03. The company had revenue of $39.56 million for the quarter, compared to the consensus estimate of $37.21 million. The company’s revenue for the quarter was up 37.3% on a year-over-year basis. Analysts expect that Cardiovascular Systems will post $-1.11 EPS for the current fiscal year.
Several analysts have recently commented on the stock. Analysts at Benchmark Co. raised their price target on shares of Cardiovascular Systems from $38.00 to $42.00 in a research note on Thursday, August 7th. They now have a “buy” rating on the stock. Analysts at Needham & Company LLC raised their price target on shares of Cardiovascular Systems from $37.00 to $38.00 in a research note on Thursday, August 7th. They now have a “strong-buy” rating on the stock. Four equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $40.67.
Cardiovascular Systems, Inc (NASDAQ:CSII) is a medical device company.
Receive News & Ratings for Cardiovascular Systems Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.